| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
-peptides enhance vasoconstriction in cerebral
circulation
1 Center for Clinical and Molecular Neurobiology, Department of Neurology, and 2 Division of Pulmonary Critical Care, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota 55455; and 3 McLaughlin Research Institute, Great Falls, Montana 59405
Amyloid-
(A)-peptides are involved in the
pathophysiology of Alzheimer's dementia. We studied the effects of
A on selected constrictor responses of cerebral circulation. Mice
were anesthetized (by using urethane-chloralose) and equipped with a
cranial window. Arterial pressure and blood gases were monitored and
controlled. Cerebral blood flow (CBF) was monitored by a laser Doppler
probe. Topical superfusion with A1-40 (0.1-10 µM), but
not with the reverse peptide A40-1, reduced resting CBF
(
29 ± 4% at 5 µM; P < 0.05) and augmented
the reduction in CBF produced by the thromboxane analog U-46619
(+45 ± 3% at 5 µM; P < 0.05). A1-40
or A1-42 did not affect the reduction in CBF produced by
hypocapnia. The reduction in resting CBF and the enhancement of
vasoconstriction were reversed by treatment with the free radical
scavengers superoxide dismutase or
manganic(I-II)meso-tetrakis(4-benzoic acid)porphyrin. Substitution of the methionine residue in position 35 with norleucine, a mutation that abolishes the ability of A to produce free radicals, abolished its vascular effects. Nanomolar concentrations of
A1-40 constricted isolated pressurized middle cerebral artery
segments with intrinsic tone (16 ± 3% at 100 nM;
P < 0.05). We conclude that A acts directly on
cerebral arteries to produce vasoconstriction and to enhance selected
constrictor responses. The evidence supports the idea that A-induced
production of reactive oxygen species plays a role in this effect. The
vascular actions of A may contribute to the deleterious effects
resulting from accumulation of this peptide in Alzheimer's dementia.
Alzheimer's disease; cerebral blood flow; reactive oxygen species; laser Doppler flowmetry
This article has been cited by other articles:
|
|
 |
|
  A. M. Abbatecola, M. Barbieri, M. R. Rizzo, R. Grella, M. T. Laieta, E. Quaranta, A. M. Molinari, M. Cioffi, P. Fioretto, and G. Paolisso Arterial Stiffness and Cognition in Elderly Persons With Impaired Glucose Tolerance and Microalbuminuria J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2008; 63(9): 991 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N.-W. Hu, I. M. Smith, D. M. Walsh, and M. J. Rowan Soluble amyloid-{beta} peptides potently disrupt hippocampal synaptic plasticity in the absence of cerebrovascular dysfunction in vivo Brain, September 1, 2008; 131(9): 2414 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Park, P. Zhou, R. Pitstick, C. Capone, J. Anrather, E. H. Norris, L. Younkin, S. Younkin, G. Carlson, B. S. McEwen, et al. Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor protein PNAS, January 29, 2008; 105(4): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. K. Shin, P. B. Jones, M. Garcia-Alloza, L. Borrelli, S. M. Greenberg, B. J. Bacskai, M. P. Frosch, B. T. Hyman, M. A. Moskowitz, and C. Ayata Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy Brain, September 1, 2007; 130(9): 2310 - 2319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. M. Faraci, M. L. Modrick, C. M. Lynch, L. A. Didion, P. E. Fegan, and S. P. Didion Selective cerebral vascular dysfunction in Mn-SOD-deficient mice J Appl Physiol, June 1, 2006; 100(6): 2089 - 2093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M. Faraci Reactive oxygen species: influence on cerebral vascular tone J Appl Physiol, February 1, 2006; 100(2): 739 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Girouard and C. Iadecola Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease J Appl Physiol, January 1, 2006; 100(1): 328 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-K. Tong, N. Nicolakakis, A. Kocharyan, and E. Hamel Vascular Remodeling versus Amyloid {beta}-Induced Oxidative Stress in the Cerebrovascular Dysfunctions Associated with Alzheimer's Disease J. Neurosci., November 30, 2005; 25(48): 11165 - 11174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Park, J. Anrather, P. Zhou, K. Frys, R. Pitstick, S. Younkin, G. A. Carlson, and C. Iadecola NADPH Oxidase-Derived Reactive Oxygen Species Mediate the Cerebrovascular Dysfunction Induced by the Amyloid {beta} Peptide J. Neurosci., February 16, 2005; 25(7): 1769 - 1777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Iadecola Atherosclerosis and Neurodegeneration: Unexpected Conspirators in Alzheimer's Dementia Arterioscler. Thromb. Vasc. Biol., November 1, 2003; 23(11): 1951 - 1953. [Full Text] [PDF]
|
|
|
|
 |
|
 V. L. Kinnula and J. D. Crapo Superoxide Dismutases in the Lung and Human Lung Diseases Am. J. Respir. Crit. Care Med., June 15, 2003; 167(12): 1600 - 1619. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Niwa, K. Kazama, L. Younkin, S. G. Younkin, G. A. Carlson, and C. Iadecola Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H315 - H323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.C. de la Torre Alzheimer Disease as a Vascular Disorder: Nosological Evidence Stroke, April 1, 2002; 33(4): 1152 - 1162. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
